Open Government Portal
Found 10 records similar to AIDS bureau locations
In 2016, an estimated 63,110 people were living with HIV.
This evaluation covered the activities of the Federal Initiative (FI) to Address HIV/AIDS in Canada for the period of 2013-14 to 2017-18. FI represents an annual investment ranging from $70 to $78 million. The evaluation was undertaken in fulfillment of the requirements of the Financial Administration Act and the Treasury Board of Canada's Policy on Results (2016).
Canada's Access to Medicines Regime is intended to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other diseases.
What health professionals need to know about HIV and AIDS, prevention, disease progression, clinical manifestations, diagnosis, treatment and surveillance.
Find information, tools and facts about symptoms, risks and how to prevent, treat and manage HIV and AIDS.
The human immunodeficiency virus (HIV) and the human T-cell lymphotropic virus type 1 (HTLV-1) are examples of RG3 pathogens where the pathogen risk and CL assessments have been revisited by the Agency in conjunction with HIV/HTLV specialists based on current risks associated with activities involving these pathogens. It has been determined that HIV & HTLV-1 can be safely handled at CL2/CL2-Ag with specific additional operational requirements (see Section 4.0). This Biosafety Directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent CL decisions, and considerations that have been made for those working with HIV and HTLV-1. The Biosafety Directive for HIV and HTLV-1 is to be used in conjunction with the CBSG.
The number of persons who are infected with HIV and not yet tested (i.e. are not even aware themselves that they have HIV) is impossible to know precisely. This number is estimated using statistical models and methods with data from a variety of sources.
In 2018, 50% of Canadians had never been tested for HIV, hepatitis C, or STI.
HIV diagnosis rates remained stable over the last decade, with some minor fluctuations.